The Turf War: Private Equity, Hospital M&A, and the Consolidation of the Turf
Hospital M&A momentum is accelerating, with 18 announced mergers in Q2 2026, while physician medical groups captured a r...
Read More →Hospital M&A momentum is accelerating, with 18 announced mergers in Q2 2026, while physician medical groups captured a r...
Read More →The clinical trial progress for radiopharmaceuticals is colliding with severe safety and isotope supply chain setbacks, ...
Read More →The FDA has launched a pilot program utilizing AI to review clinical trial data in real-time, starting with a proof-of-c...
Read More →Kalshi has introduced prediction markets for clinical trials and FDA approvals, allowing users to bet on Phase 3 outcome...
Read More →A new oral GLP-1 strategy delivered up to 12% body weight reduction in 36 weeks, sparking a high-stakes pill battle betw...
Read More →The 2026 convergence of the NO FAKES Act, the $1 billion liquidation of Rhode, and the mass migration of celebrity capit...
Read More →The 2026 convergence of the FDA's bespoke CRISPR framework, the NIH's 25-tumor data catalog, and a $1.27B surge in DOD m...
Read More →Over a 72-hour window, clinical research validated the systemic spillover effects of GLP-1s, dietary bioactives, and rec...
Read More →A newly published randomized controlled trial indicates that eating 200 grams of raw tomatoes and 50 grams of tomato sau...
Read More →Harvard geneticist Dr. David Sinclair has launched Lifespan.com, a scientist-led media platform designed to combat rampa...
Read More →Shoreline Mafia rapper Fenix Flexin has clarified his use of AI in creating his viral hit "Rubberz," which recently hit ...
Read More →A randomised controlled trial published in Nature Medicine reveals that a daily postbiotic supplement of pasteurized Akk...
Read More →